The Beginning of Icodextrin

Popovich R.P. , Moncrief J.W. , Decherd J.F. , Bomar J.B. , Pyle W.K. The definition of a novel portable/wearable equilibrium dialysis technique. Trans Am Soc Artif Int Organs 1976; 5: 64.

Gokal R. Continuous ambulatory peritoneal dialysis (CAPD)—ten years on. Q J Med 1987; 63: 465–72.

Mistry C.D. , Gokal R. New osmotic agents for peritoneal dialysis: where we are and where we're going. Semin Dial 1991; 4: 9–12.

Rubin J. , Jones Q. , Planch A. , Bower J. , Klein E. Substitution of a starch polymer for glucose in peritoneal dialysis. Nephron 1985; 39: 40–6.

Winchester J.F. , Stegink L.D. , Ahmad S. , Gross M. , Hammeke M. , Horowitz J.F. A comparison of glucose polymer and dextrose as osmotic agents in CAPD. In: Maher J.F. , Winchester J.F. , eds. Frontiers in Peritoneal Dialysis. New York: Field, Rich and Associates; 1986: 231–40.

Berlyne G.M. , Booth E.M. , Brewis R.A. , Mallick N.P. A soluble glucose polymer for use in renal failure and calorie-deprivation states. Lancet 1969; 1: 689–92.

Ricketts C.R. Sugars and dextrins for dietary use. In: Mallick N.P. , ed. Glucose Polymer in Health and Disease. The Role of Caloreen. Lancaster: MTP Press; 1977: 45–52.

Mistry C.D. Glucose polymer as an osmotic agent in continuous peritoneal dialysis [Thesis]. London: University of London; 1989.

Mistry C.D. , Gokal R. , Mallick N.P. Glucose polymer as an osmotic agent in continuous peritoneal dialysis (CAPD). In: Maher J.F. , Winchester J.F. , eds. Frontiers in Peritoneal Dialysis. New York: Field, Rich and Associates; 1986: 241–8.

Mistry C.D. , Fox J.E. , Mallick N.P. , Gokal R. Circulating maltose and isomaltose in chronic renal failure. Kidney Int 1987; 32(Suppl 22): S210–14.

Kiil F. Mechanism of osmosis. Kidney Int 1982; 21: 303–8.

Staverman P.J. The theory of measurement of osmotic pressure. Recl Trav Chim (Pays-Bas Belg) 1951; 70: 344–52.

Mistry C.D. , Mallick N.P. , Gokal R. The advantage of glucose polymer (Mw 20,000) as an osmotic agent in CAPD. Proc EDTA ERA 1985; 22: 415–20.

Mistry C.D. , Mallick N.P. , Gokal R. Ultrafiltration with isosmotic solution during long peritoneal dialysis exchanges. Lancet 1987; ii: 178–82.

Daugirdas J.T. , Ing T.S. , Gandhi V.C. , Hano J.E. , Chen W. , Yuam L. Kinetics of peritoneal fluid absorption in patients with chronic renal failure. J Lab Clin Med 1980; 95: 351–61.

Rippe B. , Stein G. , Ahlmen J. Lymph flow from the peritoneal cavity in CAPD patients. In: Maher J.F. , Winchester J.F. , eds. Frontiers in Peritoneal Dialysis. New York: Field, Rich and Associates; 1986: 24–30.

Mistry C.D. , Gokal R. Can ultrafiltration occur with a hypo-osmolar solution in peritoneal dialysis?: The role for ‘colloid’ osmosis. Clin Sci 1993; 85: 495–500.

Mistry C.D. , Bhowmick B. , Ashnam R. , Uttley L. Clinical studies of new icodextrin formulations. Perit Dial Int 1994; 14(Suppl 2): S55–7.

Mistry C.D. , Gokal R. Icodextrin in peritoneal dialysis: early development and clinical use. Per it Dial Int 1994; 14(Suppl 2): S13–21.

Mistry C.D. , Gokal R. A single daily overnight (12 hr dwell) use of 7.5% glucose polymer (Mw 18,700; Mn 7,300) + 0.35% glucose solution: a 3 month study. Nephrol Dial Transplant 1993; 8: 443–47.

Mistry C.D. , Gokal R. , Peers MA ; Midas Study Group. A randomized multicenter clinical trial comparing isosmolar dextrin 20 with hyperosmolar glucose solutions in continuous ambulatory peritoneal dialysis (CAPD): a six month study. Kidney Int 1994; 46: 496–503.

Mistry C.D. , O'Donoghue D.J. , Nelson S. , Gokal R. , Ballardie F.W. Kinetic and clinical studies of beta 2-microglobulin in continuous ambulatory peritoneal dialysis: influence of renal and enhanced peritoneal clearances using glucose polymer. Nephrol Dial Transplant 1990; 5: 513–19.

Topley N. , Liberek T. , Mistry C. , Coles G.A. , Williams J.D. Cell function, viability and icodextrin. Perit Dial Int 1994; 14(Suppl 2): S28–32.

Blake P.G. Icodextr in: fifteen years and counting. Per it Dial Int 2009; 29: 367–9.